Antipruritic vs. Antitumour Action of Aprepitant: A Question of Dose
Saved in:
Main Authors: | Miguel Muñoz (Author), Julio Parrilla (Author), Marisa Rosso (Author), Rafael Coveñas (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discussion on the Antipruritic Mechanism of Qiwei Antipruritic Based on Network Pharmacology and Molecular Docking Technology
by: Wang L, et al.
Published: (2023) -
The Neuromodulatory Effect of Antipruritic Treatment of Chronic Prurigo
by: Claudia Zeidler, et al.
Published: (2019) -
Systematic review on antipruritic therapies for patients with Epidermolysis bullosa
by: Tobias Welponer, et al.
Published: (2024) -
Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects
by: Hao-Jui Weng, et al.
Published: (2022) -
The Antitumour Mechanisms of Carotenoids: A Comprehensive Review
by: Andrés Baeza-Morales, et al.
Published: (2024)